These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2298466)

  • 61. The effect of high calcium intake on Ca2+ ATPase and the tissue Na:K ratio in spontaneously hypertensive rats.
    Wuorela H; Arvola P; Pörsti I; Siltaloppi E; Säynävälammi P; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):117-22. PubMed ID: 1531700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Importance of chloride for deoxycorticosterone acetate-salt hypertension in the rat.
    Passmore JC; Whitescarver SA; Ott CE; Kotchen TA
    Hypertension; 1985; 7(3 Pt 2):I115-20. PubMed ID: 3997231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The characteristics of renal mineralocorticoid receptors in glycyrrhizinic acid or deoxycorticosterone-induced hypertensive rats.
    Hayashi T; Nakai T; Uchida K; Morimoto S; Takeda R
    Clin Exp Hypertens A; 1984; 6(9):1625-40. PubMed ID: 6239715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suppression of adrenal renin in Dahl salt-sensitive rats.
    Baba K; Mulrow PJ; Franco-Saenz R; Rapp JP
    Hypertension; 1986 Dec; 8(12):1149-53. PubMed ID: 3539795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
    Nirasawa Y; Temma K; Fink GD; Akera T
    Life Sci; 1985 Aug; 37(8):767-74. PubMed ID: 2991692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Water immersion and salt-sensitivity in essential hypertension.
    Coruzzi P; Musiari L; Mossini GL; Ceriati R; Novarini A
    Scand J Clin Lab Invest; 1993 Oct; 53(6):593-9. PubMed ID: 8266005
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of calcium supplementation and deoxycorticosterone on plasma atrial natriuretic peptide and electrolyte excretion in spontaneously hypertensive rats.
    Pörsti I; Wuorela H; Arvola P; Mämmi P; Nurmi AK; Koistinaho J; Laippala P; Vapaatalo H
    Acta Physiol Scand; 1991 Mar; 141(3):343-50. PubMed ID: 1830445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Whey mineral supplementation and arterial tone in mineralocorticoid-NaCl hypertension.
    Wu X; Mäkynen H; Korpela R; Pörsti I
    Cardiovasc Res; 1996 Dec; 32(6):1115-22. PubMed ID: 9015414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in vascular ionic composition at different stages of DOC-salt hypertension in the rat.
    Villamil MF; Amorena C; Ponce J; Müller A; Taquini AC
    Clin Sci (Lond); 1981 Jul; 61(1):115-8. PubMed ID: 7249551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The occurrence of 11-deoxycorticosterone (DOC)-induced hypertension in the Long-Evans rat.
    Brownie AC; Gallant S; Nickerson PA; Joseph LM
    Endocr Res Commun; 1978; 5(1):71-80. PubMed ID: 710367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aortic ornithine decarboxylase activity in deoxycorticosterone/salt hypertensive rats.
    Leitschuh M; Hingorani V; Brecher P; Chobanian AV
    Life Sci; 1991; 48(5):465-8. PubMed ID: 1992288
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats.
    Mäkynen H; Arvola P; Vapaatalo H; Pörsti I
    Am J Hypertens; 1994 Jun; 7(6):520-8. PubMed ID: 7917150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion.
    Young DB; Pan YJ
    J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318
    [TBL] [Abstract][Full Text] [Related]  

  • 77. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
    Patel A; Layne S; Watts D; Kirchner KA
    Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renin secretion and renal vascular resistance following prolonged administration of desoxycorticosterone (DOC) in rats drinking normal saline.
    Vandongen R; Tunney A
    Clin Exp Pharmacol Physiol; 1980 Jul; 7(4):391-8. PubMed ID: 6998621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic and regional hemodynamic effects of dietary calcium supplementation in mineralocorticoid hypertension.
    DiPette DJ; Greilich PE; Kerr NE; Graham GA; Holland OB
    Hypertension; 1989 Jan; 13(1):77-82. PubMed ID: 2910816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Age-dependent salt-induced hypertension in the rat: prevention with DSP-4, a selective noradrenergic neurotoxin.
    Soltis EE; Newman PS
    Clin Exp Hypertens A; 1991; 13(4):557-72. PubMed ID: 1934539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.